Css LLC Adverum Biotechnologies, Inc. Put Options Transaction History

Css LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2022 May 16, 2022	SELL	$1.23 - $1.95 $17,220 - $27,300	-14,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $47,040 - $147,840	14,000 New	14,000 $49,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.